Biologics Manufacturing and Nonclinical Services

Award Notice Posted

Solicitation number
75N95022D00023
Agency
Awarded
to Advanced Bioscience Laboratories, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75N95022D00023 Federal IDV award
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research

Notice details come from SAM.gov. Updated .

About this opportunity

This multiple-award IDIQ contract was awarded by the National Institutes of Health National Institute on Drug Abuse to Advanced Bioscience Laboratories, Inc. for biologics manufacturing and nonclinical services. With a maximum ordering value of $149.2 million, the contract allows for both fixed-price and cost-reimbursement task orders to support new R&D programs given the uncertainty around estimating costs for performance. The SOW involves biologics manufacturing and nonclinical services to support research and development.

Notice text

This is a multiple-award indefinite delivery, indefinite quantity (IDIQ) contract, which was awarded following a competitive solicitation. The total contract value represents the IDIQ maximum ordering value; all funds will be obligated at the task order level. This contract allows for the issuance of both fixed-price and cost-reimbursement type task orders. As the Statement of Work (SOW) entails  research and develoment (R&D) services that will be supporting new programs, the Government cannot estimate the costs of performance with a reasonable or acceptable degree of accuracy. As a result, it was determined that limiting the contract to fixed-price task orders was not in the best interest of the Government.

Awarded contract 75N95022D00023 to Advanced Bioscience Laboratories, Inc. for 149200000.00 on 2022-09-28.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors